Clinical Trials Update:&nbsp;Sept. 21, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
25097
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
603771
roundup Plus: Shopping.com holders cut IPO shares...Transmeta starts new chip, warns on earnings...Keynote to buy researcher Vividence.
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
5466
MONDAY, Sept. 10 (HealthDay News) -- Little more than one in eight phase II cancer clinical trials with encouraging results go forward to the larger, phase III stage that&#39;s needed to bring a new therapy to patients, a new study finds.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
319964
The embattled pharmaceutical industry announced its intention Thursday to publish more data about clinical drug trials, despite skepticism about whether the initiative will really increase transparency and improve drug safety.
303689
Acorda announces positive clinical trial data.
402115
Two drugs provide good results in preliminary trials.
153875
BOSTON, Oct. 29 /PRNewswire/ -- Data to be presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) demonstrated that treatment with the Bristol-Myers Squibb
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
671952
THURSDAY, Jan. 27 (HealthDayNews) -- The results of a multi-center trial involving a quartet of drugs may bring fresh hope to patients battling advanced colorectal cancer, researchers reported Thursday.
730807
WASHINGTON - The Food and Drug Administration (news - web sites) will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.